OE33 Cells
General information
| Description | OE33 is a human oesophageal adenocarcinoma cell line derived from a primary tumor associated with Barrett’s oesophagus. This cell line is extensively used in research to explore the molecular biology and therapeutic responses of oesophageal adenocarcinoma, particularly in the context of Barrett’s oesophagus progression. OE33 provides a relevant model for understanding the pathogenesis of this cancer, which has been increasing in incidence and is associated with poor prognosis in advanced stages. OE33 cells display epithelial morphology and grow adherently under standard culture conditions. The cell line is characterized by molecular features typical of oesophageal adenocarcinoma, including mutations and dysregulated pathways involved in tumorigenesis, such as p53 and HER2/neu signaling. OE33 is particularly useful for investigating cellular responses to therapeutic interventions targeting HER2/neu and other pathways implicated in cancer progression and resistance. This cell line also serves as a tool for studying the interactions between tumor cells and their microenvironment, as well as mechanisms of metastasis and immune evasion. In preclinical research, OE33 is widely employed in drug screening to evaluate the efficacy of chemotherapy, targeted therapies, and novel treatment combinations aimed at improving outcomes for oesophageal adenocarcinoma. Additionally, the cell line is used in xenograft models to assess tumorigenicity and therapeutic responses in vivo. OE33’s clinical relevance and molecular characteristics make it an invaluable resource for advancing our understanding of oesophageal adenocarcinoma and developing effective treatments for this aggressive disease. |
|---|---|
| Organism | Human |
| Tissue | Esophagus |
| Disease | Adenocarcinoma |
| Synonyms | OE-33, JROECL 33, JROECL33, OEC33 |
Characteristics
| Age | 73 years |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Morphology | Epithelial-like |
| Growth properties | Adherent, single cells and clusters |
Regulatory Data
| Citation | OE33 (Cytion catalog number 305458) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0471 |
Biomolecular Data
| Viruses | EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HPV -, HTLV-I/-II -, MLV - |
|---|---|
| Mutational profile | Mutation: TP53, Simple, p.Cys135Tyr (c.404G>A), Unspecified |
Handling
| Culture Medium | RPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | The 1:1 mixture of EDTA (stock. 0.05%) and trypsin (stock: 0.1%) must be prepared each time ahead of detaching the cells using PBS without Ca2+ and Mg2+ to provide a physiologic osmolarity. Ready-to-use mixtures of trypsin/EDTA are not recommended, as this may result in cell clumps. As an alternative, TrypLE Express (Life Technologies) instead of trypsin/EDTA can be used. The protocol of the manufacturer should be followed. |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 2-4*10^4/cm² |
| Fluid renewal | 1 to 2 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305458-290626 | Certificate of Analysis | 13. Aug. 2026 | 305458 |